SOPH

Handel nachbörslich: 3.07 -0.07 -2.23%

Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1150)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Vergleichen Sie SOPH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	3.14	217.87M	64.49M	-71.40M	-52.00M	-1.09
VEEV Veeva Systems Inc	236.99	36.73B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	59.39	10.64B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	54.07	9.30B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	91.42	7.43B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	40.98	6.34B	906.14M	-52.62M	89.62M	-0.3621

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-18	Eingeleitet	Craig Hallum	Buy
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Vergleichen Sie SOPH mit anderen Aktien

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q1 2025 Result - Yahoo Finance

Sophia Genetics SA expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Promising Penny Stocks To Consider In April 2025 - simplywall.st

SOPHia Genetics expands testing partnership with AstraZeneca - MSN

SOPHiA Genetics (SOPH) Expands Liquid Biopsy Collaboration with AstraZeneca - GuruFocus

SOPHiA GENETICS Expands Global Collaboration With AstraZeneca To Advance Liquid Biopsy Testing - Nasdaq

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR – Company AnnouncementFT.com - Financial Times

SOPHiA GENETICS and AstraZeneca Scale Breakthrough Liquid Biopsy Testing to 30 Global Centers - Stock Titan

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR - Barchart.com

SOPHiA GENETICS SA's (NASDAQ:SOPH) market cap touched US$204m last week, benefiting both individual investors who own 51% as well as institutions - simplywall.st

The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025 - marketscreener.com

SOPHiA GENETICS Q1 2025 Earnings: AI Healthcare Leader Reports Financial Results May 6 - Stock Titan

SOPHiA GENETICS (SOPH) Forecasts Revenue Growth Despite Volatili - GuruFocus

SOPHiA GENETICS (SOPH) Forecasts Revenue Growth Despite Volatility - GuruFocus

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM Platform and its Liquid Biopsy Capabilities - MarketScreener

SOPHiA GENETICS Partners With Precision for Medicine - marketscreener.com

Major AI Breakthrough: SOPHiA GENETICS Partners to Transform Clinical Trial Analysis - Stock Titan

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities - MarketScreener

Precision Medicine Software Market: Global Expansion & Growth - openPR.com

Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? - Yahoo Finance

Mesoblast (NASDAQ:MESO) & SOPHiA GENETICS (NASDAQ:SOPH) Financial Review - Defense World

SOPHiA GENETICS (SOPH) Upgraded to Buy: What Does It Mean for the Stock? - MSN

With A 25% Price Drop For SOPHiA GENETICS SA (NASDAQ:SOPH) You'll Still Get What You Pay For - Simply Wall St

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC - Barchart

Two Use Cases for AI in Healthcare - Streetwise Reports

March 2025's Promising Penny Stocks To Consider - Simply Wall St

Blood Cancer Diagnostics Market Analysis Report 2025-2030, with Quest Diagnostics, Illumina, InVivoScribe, Asuragen, Danaher, Sequenta, SkylineDx, Bio-Rad Laboratories, Alercell & Sophia Genetics - Yahoo Finance

Precision Medicine Software Market Set for Global Expansion - openPR.com

Sophia Genetics at TD Cowen Conference: AI-Powered Growth Strategy By Investing.com - Investing.com UK

SOPHiA GENETICS : To Present at the NVIDIA GTC AI Conference -March 06, 2025 at 05:30 am EST - Marketscreener.com

BTIG cuts Sophia Genetics stock price target to $5, maintains buy - Investing.com

Sophia Genetics SA (SOPH) Q4 2024 Earnings Call Highlights: Record Customer Growth Amidst ... By GuruFocus - Investing.com Canada

SOPHiA GENETICS Reports 2024 Financial Results - TipRanks

SOPHiA GENETICS Earnings Call: Mixed Results, Optimistic Outlook - TipRanks

Sophia Genetics SA reports results for the quarter ended December 31Earnings Summary - TradingView

SOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates - MSN

Earnings call transcript: Sophia Genetics Q4 2024 sees slight EPS miss - Investing.com

SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

SOPHiA GENETICS : Investor PresentationFebruary 2025 -March 04, 2025 at 06:53 am EST - Marketscreener.com

Sophia Genetics earnings missed by $0.02, revenue fell short of estimates - Investing.com UK

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results - PR Newswire

Principal Financial Group Inc. Sells 26,798 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World

SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - The AM Reporter

SOPHiA GENETICS (SOPH) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing - PR Newswire

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing -February 24, 2025 at 04:01 am EST - Marketscreener.com

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing – Company Announcement - Financial Times

NeoGenomics plummets on Q4 2024 bottom line miss, soft EPS guidance - MSN

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOPH